Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID‐19: a multicenter retrospective cohort study-Reference-Cited by-同舟云学术

Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID‐19: a multicenter retrospective cohort study

Published:2020-01 Issue:10 Volume:9 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin. Transl. Immunol.

Author:

Shao Ziyun¹,Feng Yongwen²³,Zhong Li⁴,Xie Qifeng⁵,Lei Ming⁶,Liu Zheying⁵,Wang Conglin⁵,Ji Jingjing⁵,Liu Huiheng⁷,Gu Zhengtao⁸,Hu Zhongwei⁶,Su Lei⁵,Wu Ming²⁵,Liu Zhifeng⁵⁹^ORCID

Affiliation:

1. Department of Nephrology General Hospital of Central Theater Command of PLA Wuhan430070China

2. Department of Critical Care Medicine and Hospital Infection Prevention and Control The Second People’s Hospital of Shenzhen & First Affiliated Hospital of Shenzhen University Health Science Center Shenzhen518035China

3. Department of Critical Care Medicine The Third People’s Hospital of Shenzhen Shenzhen518035China

4. Department of Critical Care Medicine The First Affiliated Hospital Guizhou University of Chinese Medicine Guiyang550001China

5. Department of Critical Care Medicine General Hospital of Southern Theater Command of PLA Guangzhou510010China

6. Department of Nephrology Guangzhou Eighth people's hospital Guangzhou Medical University Guangzhou510060China

7. Department of Emergency Zhongshan Hospital of Xiamen University Xiamen361000China

8. Department of Treatment Center for Traumatic Injuries The Third Affiliated Hospital Academy of Orthopedics Guangdong Province Southern Medical University Guangzhou Guangdong515630China

9. Key Laboratory of Hot Zone Trauma Care and Tissue Repair of PLA General Hospital of Southern Theater Command of PLA Guangzhou510010China

Funder

Sanming Project of Medicine in Shenzhen

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1192

Reference36 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. Risk Factors of Healthcare Workers With Coronavirus Disease 2019: A Retrospective Cohort Study in a Designated Hospital of Wuhan in China;Ran L;Clin Infect Dis,2019

3. National Health Commission of the People`s Republic of China.Chinese recommendations for diagnosis and treatment of novel coronavirus (SARSCoV2) infection (Trial 7th version). 2020.

4. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

5. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous immunoglobulin for treatment of hospitalized COVID-19 patients: an evidence mapping and meta-analysis;Inflammopharmacology;2023-12-14

2. Passive antibody therapy in emerging infectious diseases;Frontiers of Medicine;2023-12-02

3. Blood‐derived product therapies for SARS‐CoV‐2 infection and long COVID;MedComm;2023-11-15

4. Comparative effectiveness of two intravenous immunoglobulin products in children with Kawasaki disease, a nationwide cohort study;Scientific Reports;2023-10-30

5. The prevention and treatment of COVID-19 in patients treated with hemodialysis;European Journal of Medical Research;2023-10-09